These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 11935325)

  • 1. Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene.
    Seri M; Savino M; Bordo D; Cusano R; Rocca B; Meloni I; Di Bari F; Koivisto PA; Bolognesi M; Ghiggeri GM; Landolfi R; Balduini CL; Zelante L; Ravazzolo R; Renieri A; Savoia A
    Hum Genet; 2002 Feb; 110(2):182-6. PubMed ID: 11935325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Alport-like syndromes.
    Heath KE; Campos-Barros A; Toren A; Rozenfeld-Granot G; Carlsson LE; Savige J; Denison JC; Gregory MC; White JG; Barker DF; Greinacher A; Epstein CJ; Glucksman MJ; Martignetti JA
    Am J Hum Genet; 2001 Nov; 69(5):1033-45. PubMed ID: 11590545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and Sebastian syndromes. The May-Heggllin/Fechtner Syndrome Consortium.
    Seri M; Cusano R; Gangarossa S; Caridi G; Bordo D; Lo Nigro C; Ghiggeri GM; Ravazzolo R; Savino M; Del Vecchio M; d'Apolito M; Iolascon A; Zelante LL; Savoia A; Balduini CL; Noris P; Magrini U; Belletti S; Heath KE; Babcock M; Glucksman MJ; Aliprandis E; Bizzaro N; Desnick RJ; Martignetti JA
    Nat Genet; 2000 Sep; 26(1):103-5. PubMed ID: 10973259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asp1424Asn MYH9 mutation results in an unstable protein responsible for the phenotypes in May-Hegglin anomaly/Fechtner syndrome.
    Deutsch S; Rideau A; Bochaton-Piallat ML; Merla G; Geinoz A; Gabbiani G; Schwede T; Matthes T; Antonarakis SE; Beris P
    Blood; 2003 Jul; 102(2):529-34. PubMed ID: 12649151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions.
    Kunishima S; Matsushita T; Kojima T; Amemiya N; Choi YM; Hosaka N; Inoue M; Jung Y; Mamiya S; Matsumoto K; Miyajima Y; Zhang G; Ruan C; Saito K; Song KS; Yoon HJ; Kamiya T; Saito H
    J Hum Genet; 2001; 46(12):722-9. PubMed ID: 11776386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [May-Hegglin anomaly--from genome research to clinical laboratory].
    Kunishima S
    Rinsho Byori; 2003 Sep; 51(9):898-904. PubMed ID: 14560660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders.
    Pecci A; Noris P; Invernizzi R; Savoia A; Seri M; Ghiggeri GM; Sartore S; Gangarossa S; Bizzaro N; Balduini CL
    Br J Haematol; 2002 Apr; 117(1):164-7. PubMed ID: 11918549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Autosomal dominant macrothrombocytopenia with leukocyte inclusion bodies and MYH9 disorders].
    Kunishima S
    Rinsho Byori; 2009 Apr; 57(4):365-70. PubMed ID: 19489439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome).
    Ghiggeri GM; Caridi G; Magrini U; Sessa A; Savoia A; Seri M; Pecci A; Romagnoli R; Gangarossa S; Noris P; Sartore S; Necchi V; Ravazzolo R; Balduini CL
    Am J Kidney Dis; 2003 Jan; 41(1):95-104. PubMed ID: 12500226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes.
    Arrondel C; Vodovar N; Knebelmann B; Grünfeld JP; Gubler MC; Antignac C; Heidet L
    J Am Soc Nephrol; 2002 Jan; 13(1):65-74. PubMed ID: 11752022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Historical hematology: May-Hegglin anomaly.
    Saito H; Kunishima S
    Am J Hematol; 2008 Apr; 83(4):304-6. PubMed ID: 17975807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness.
    Seri M; Pecci A; Di Bari F; Cusano R; Savino M; Panza E; Nigro A; Noris P; Gangarossa S; Rocca B; Gresele P; Bizzaro N; Malatesta P; Koivisto PA; Longo I; Musso R; Pecoraro C; Iolascon A; Magrini U; Rodriguez Soriano J; Renieri A; Ghiggeri GM; Ravazzolo R; Balduini CL; Savoia A
    Medicine (Baltimore); 2003 May; 82(3):203-15. PubMed ID: 12792306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cloning of the murine non-muscle myosin heavy chain IIA gene ortholog of human MYH9 responsible for May-Hegglin, Sebastian, Fechtner, and Epstein syndromes.
    D'Apolito M; Guarnieri V; Boncristiano M; Zelante L; Savoia A
    Gene; 2002 Mar; 286(2):215-22. PubMed ID: 11943476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestation and molecular genetic characterization of MYH9 disorders.
    Provaznikova D; Geierova V; Kumstyrova T; Kotlin R; Mikulenkova D; Zurkova K; Matoska V; Hrachovinova I; Rittich S
    Platelets; 2009 Aug; 20(5):289-96. PubMed ID: 19557653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: association of subcellular localization with MYH9 mutations.
    Kunishima S; Matsushita T; Kojima T; Sako M; Kimura F; Jo EK; Inoue C; Kamiya T; Saito H
    Lab Invest; 2003 Jan; 83(1):115-22. PubMed ID: 12533692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution melting analysis for detection of MYH9 mutations.
    Provaznikova D; Kumstyrova T; Kotlin R; Salaj P; Matoska V; Hrachovinova I; Rittich S
    Platelets; 2008 Sep; 19(6):471-5. PubMed ID: 18925516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly.
    Kelley MJ; Jawien W; Ortel TL; Korczak JF
    Nat Genet; 2000 Sep; 26(1):106-8. PubMed ID: 10973260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with Epstein-Fechtner syndromes owing to MYH9 R702 mutations develop progressive proteinuric renal disease.
    Sekine T; Konno M; Sasaki S; Moritani S; Miura T; Wong WS; Nishio H; Nishiguchi T; Ohuchi MY; Tsuchiya S; Matsuyama T; Kanegane H; Ida K; Miura K; Harita Y; Hattori M; Horita S; Igarashi T; Saito H; Kunishima S
    Kidney Int; 2010 Jul; 78(2):207-14. PubMed ID: 20200500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations predicts the natural history of MYH9-related disease.
    Pecci A; Panza E; Pujol-Moix N; Klersy C; Di Bari F; Bozzi V; Gresele P; Lethagen S; Fabris F; Dufour C; Granata A; Doubek M; Pecoraro C; Koivisto PA; Heller PG; Iolascon A; Alvisi P; Schwabe D; De Candia E; Rocca B; Russo U; Ramenghi U; Noris P; Seri M; Balduini CL; Savoia A
    Hum Mutat; 2008 Mar; 29(3):409-17. PubMed ID: 18059020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the understanding of MYH9 disorders.
    Kunishima S; Saito H
    Curr Opin Hematol; 2010 Sep; 17(5):405-10. PubMed ID: 20601875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.